Research Orthopedics Pediatrics
Returning to moderate to vigorous physical activity (MVPA) after a concussion may play a vital role in helping teens feel less anxious while recovering from the injury, according to a new study from researchers in the Department of Orthopedics at the University of Colorado School of Medicine.
Eric J. Earley, PhD, a new faculty member in the Department of Orthopedics in the University of Colorado School of Medicine, is bringing his expertise in prosthetic limbs to the department’s Osseointegration Research Consortium. Led by Jason Stoneback, MD, the lab is focused on developing and improving bone-anchored limb technology aimed at creating prosthetic limbs that can be directly inserted into bones, as opposed to the traditional prosthetic that attaches via a socket that goes around the outside of the limb.
Checking the donor box on your driver’s license application doesn’t just qualify you to donate organs such as kidneys, heart, and lungs; it also allows you to donate musculoskeletal tissue to patients awaiting repair of knees, ankles, and damaged tendons, ligaments, and cartilage.
Community Sports Medicine Orthopedics
With session titles like “Commando and Military Injuries: Late Night Stories,” “Surfing in the Olympics,” and “Cave Diving: The Deadliest Extreme Sport on Earth, or Not?,” you can tell this isn’t your average medical conference.
CPR
July 25, 2024
In Colorado and across the nation, emergency departments at pediatric hospitals are overflowing with kids who need intensive mental health treatment.
9News
July 23, 2024
A little more than a month after the Olympics wrap up, women triathletes will be heading to the south of France for another competition on the global stage.
Healthy Debate
July 18, 2024
In 1961, Yuri Gagarin became the first human in space. With every kilometre he ascended, he pushed the boundaries of human achievement and catalyzed a surge of interest in exploration, research, development – and medical innovation.
Medscape
July 18, 2024
Experts debating the pressing issue of how to prioritize patients in the increasingly common scenario of loss of access or insurance coverage for anti-obesity glucagon-like peptide 1 (GLP-1) receptor agonist drugs argued that comorbidities and obesity severity should strongly warrant continued coverage — while offering key strategies for getting and retaining approval from payers.
Kara Mason
